In B-cell lymphoma, TOX is overexpressed in precursor B lymphoblastic lymphoma (B-LBL), diffuse large B cell lymphoma (DLBCL), follicular lymphoma (FL), and a small proportion of Burkitt lymphoma (BL) patients. Here, TOX is linked to Burkitt lymphoma.